Blood sample collection for plasma cell disorders
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study is collecting blood samples from people with plasma cell disorders to help researchers learn more about these conditions. It may be a good fit if you haven't started treatment yet and are willing to donate samples.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a plasma cell disorder (MGUS, smoldering myeloma, active multiple myeloma, or plasma cell leukemia).
- You must be at least 18 years old.
- You must be able to give your permission (written informed consent).
- You cannot have started anti-myeloma treatment before joining (except one emergency course if needed).
- You must not have had a serious reaction to giving blood in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies myeloma (and closely related blood disorders) by using extra blood or bone marrow samples for lab research. It aims to help discover new ways to understand or treat myeloma.
This study collects and stores blood/tissue samples (called biospecimens) to support immunotherapy research at the cancer center. If you may qualify, your samples help researchers test new immune-based cancer treatments.
This study collects health information and, if needed, samples from people diagnosed with certain blood disorders related to plasma cells. Sharing your information may help researchers better understand these diseases and improve future care.
This trial is testing a new type of blood test (called a liquid biopsy) to find multiple myeloma early by looking at tiny pieces of DNA in your blood. It is for people already diagnosed with multiple myeloma, smoldering multiple myeloma, or MGUS.
This study looks at stored blood (serum) samples to see whether a lab test called MALDI-TOF mass spectrometry can help analyze multiple myeloma proteins. If you have multiple myeloma (or are a healthy matched control), your existing lab samples may be used for testing.
This study looks at how multiple myeloma (a bone marrow cancer) changes over time, especially why it becomes resistant to treatment or comes back. It may help researchers learn what drives relapse and could lead to better future treatments.
Hear when a new Multiple myeloma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.